China’s Blue Planet Science-Fiction Film Festival Highlighted in “Focus on China” event at 78th Venice International Film Festival
7.9.2021 19:11:00 EEST | Business Wire | Press release
China’s Blue Planet Science-Fiction Film Festival (BPSFF), launched by Xinhuanet, was highlighted in the “Focus on China” event at the 78th Venice International Film Festival (VIFF) on Sept. 5. The event, held through a combination of online and offline activities, featured notable guests from Italy and China and focused on the cultivation of young film & TV talent and international cooperation amidst the pandemic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210907005705/en/
China’s Blue Planet Science-Fiction Film Festival Highlighted in “Focus on China” event at 78th Venice International Film Festival (Graphic: Business Wire)
"At this special time, this kind of cultural exchange between China and Italy carries important symbolism. Practical challenges have not hindered our cultural cooperation," said Francesco Rutelli, president of the Italian Association of Film, Audio-visual and Digital Industry (ANICA), a co-host of the “Focus on China” event.
"This year is the 6th edition of the VIFF's 'Focus on China' event. It has been a long journey and we will continue to promote such exchanges," said Rutelli. "Beijing will soon host the Winter Olympics and Milan and Cortina d'Ampezzo in Italy will host the next one – a kind of 'relay' that connects China and Italy."
At the event, Wang Zhenzheng, chief content officer of the BPSFF, gave a presentation on the theme “Symbiosis - Talent cultivation, Industry links, and Imagination flow.” After two years of development, BPSFF has become China's largest sci-fi film festival – as well as the largest platform for sci-fi film professionals and filmmaking talent; the largest platform for sci-fi content, and a key platform for cross-border exchange in science and technology.
Since the first edition in 2019, the BPSFF has attracted over 500 sci-fi films from more than 30 countries and regions around the world. It has become a platform for new exploration to showcase the vision of young sci-fi filmmakers from China and around the world.
"This November, the 3rd Blue Planet Science-Fiction Film Festival will be held under the theme of 'Migrating' – allowing fresh ideas and imagination to flow around the world and add a special 'New Species' section to showcase sci-fi for young people," said Wang.
This year’s “Focus on China” event also featured the BPSFF, a special market screening session at VIFF of selected Chinese sci-fi films, including Newborns Lawyer directed by Chen Yuhang, Nihilism by Deng Di, A short Dream by Shu Haolun, The Castle up Cloud by Luo Bofan.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005705/en/
Contact information
Shelly Wang
info@xinhuaneteurope.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SuperElastic* Material Unveiled by Angelalign2.11.2026 19:46:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel”)http://www.angelaligner.com, a global clear aligner leader, today unveiled SuperElastic (MC-SE*), a new propietary aligner material that is a significant breakthrough in performance over its current material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261102654659/en/ Specialists in orthodontics have long asked for new aligner materials that enable better treatment for complex cases: biologically safe force levels, a large elastic working range, and strength and toughness. MC-SE* provides all of them. “Angel is commited to innovation and never settling for 'good enough'. MC-SE* is the result of seven years of materials research, testing and manufacturing optimization. The new material aims to create a new generation of aligner material that allows orthodonists to differentiate their treatment from other treatments,“ said Fox Hu, CEO of Angel. MC-SE will be available globally
Galderma Announces Proposed Board Appointments and Chief Financial Officer Transition2.11.2026 19:00:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced proposed changes to its Board of Directors, aimed at further strengthening its governance and supporting its long-term growth. The company also announced that Luigi La Corte, Chief Financial Officer (CFO), has decided to leave Galderma to pursue a significant new opportunity. Luigi La Corte will continue to fulfil his responsibilities as CFO during the transition period, supporting business continuity and a smooth handover. The company will communicate further details regarding succession arrangements and the transition timeline in due course. The Board of Directors is proposing the election of Rosalind Brewer and Petra Rumpf as new Board members. Both candidates bring extensive leadership and governance experience, alongside expertise spanning consumer-facing businesses, healthcare, medtech and life sciences. As Galderma advances its ambition to become the undisputed dermatology powerhouse, spanni
Donaldson Introduces Alpha-Pore™ Technology Platform for Extended Sterile Filtration Performance2.11.2026 16:35:00 EET | Press release
Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration products and solutions, today announced Alpha‑Pore™ technology, a next generation sterile filtration platform engineered to extend filter service life while maintaining critical process performance. Built for critical applications, Alpha‑Pore technology enables longer filter run time compared with competitive single- and dual-layer polyethersulfone (PES) membrane filters, while maintaining flow characteristics, sterility assurance, and process integrity.* The platform is designed to help manufacturers improve operational efficiency through fewer changeouts and more consistent performance over time. Engineered for Extended Performance Sterile filtration processes often require balancing run time with key performance parameters such as flow, differential pressure, and contaminant retention. Alpha‑Pore technology is designed to achieve all three. By optimizing pore structure and filter architect
Smartly Launches Intelligence Pro to Connect Campaign Planning, Performance and Incrementality2.11.2026 16:00:00 EET | Press release
Smartly, the AI-powered advertising technology company, today launched Intelligence Pro, a premium offering that brings together four capabilities to help marketers plan investment, understand true incrementality and determine where to spend their next dollar. Intelligence Pro connects causal inference models with planning tools to help marketers prove business impact and make faster decisions from increasingly complex data. “Marketing teams are inundated with data, but the challenge is identifying what signals are useful and turning them into a decision they can act on,” said Maxwell Tang, Chief Product Officer at Smartly. “Intelligence Pro brings forecasting, market context and state-of-the-art incrementality signals together to help marketers assess where to invest and what their media is contributing. As AI accelerates campaign execution, the quality of each decision matters more.” Intelligence Pro combines four capabilities within Smartly’s platform: Reach Planner helps teams comp
SBC Medical Forms Capital and Business Alliance with AtomicSoftware, Provider of the medicalforce Clinic Management Platform Used by 800+ Clinics in Japan2.11.2026 16:00:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that it entered into a capital and business alliance agreement on October 26, 2026, with AtomicSoftware Inc. (“AtomicSoftware”), the Tokyo-based provider of medicalforce, an all-in-one software-as-a-service (SaaS) platform for clinics. In connection with the alliance, SBC Medical has invested ¥600 million (approximately US$3.8 million) in AtomicSoftware’s Series C funding round. The two companies will co-develop AI features, beginning with a feature that supports physicians in preparing medical records. Key Highlights Proven platform: medicalforce is used by more than 800 clinics*1 in Japan, primarily self-pay clinics, with a clinic retention rate of 99.2%*2. Joint AI development: Features co-developed by the two companies will enhance medicalforce and be progressively incorpo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom